PubRank

D W Bonhaus

Author PubWeight™ 34.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Characterization and distribution of putative 5-ht7 receptors in guinea-pig brain. Br J Pharmacol 1995 1.71
2 The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro. Br J Pharmacol 1995 1.57
3 Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors. Br J Pharmacol 1998 1.54
4 Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase. Br J Pharmacol 1997 1.29
5 RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification. Mol Pharmacol 1996 1.27
6 Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist-mediated [35S]GTPgammaS binding. Biochem Pharmacol 1998 1.26
7 Cloning and expression of a 5-hydroxytryptamine7 receptor positively coupled to adenylyl cyclase. J Neurochem 1994 1.18
8 RS 39604: a potent, selective and orally active 5-HT4 receptor antagonist. Br J Pharmacol 1995 0.99
9 Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models. Neuropharmacology 1988 0.98
10 RS 23597-190: a potent and selective 5-HT4 receptor antagonist. Br J Pharmacol 1993 0.98
11 Pharmacological characterization of two novel and potent 5-HT4 receptor agonists, RS 67333 and RS 67506, in vitro and in vivo. Br J Pharmacol 1995 0.95
12 Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat. Br J Pharmacol 1995 0.95
13 Labelling of 5-hydroxytryptamine3 receptors with a novel 5-HT3 receptor ligand, [3H]RS-42358-197. J Neurochem 1993 0.93
14 N-methyl-D-aspartate receptor plasticity in kindling: quantitative and qualitative alterations in the N-methyl-D-aspartate receptor-channel complex. Proc Natl Acad Sci U S A 1989 0.92
15 Quantitative autoradiography of 5-HT4 receptors in brains of three species using two structurally distinct radioligands, [3H]GR113808 and [3H]BIMU-1. Neuropharmacology 1994 0.90
16 2-(Quinuclidin-3-yl)pyrido[4,3-b]indol-1-ones and isoquinolin-1-ones. Potent conformationally restricted 5-HT3 receptor antagonists. J Med Chem 1993 0.89
17 Kindling induces the long-lasting expression of a novel population of NMDA receptors in hippocampal region CA3. J Neurosci 1994 0.87
18 Characterization of [3H]GR 113808 binding to 5-HT4 receptors in brain tissues from patients with neurodegenerative disorders. Behav Brain Res 1996 0.86
19 Increased AMPA-sensitive quisqualate receptor binding and reduced NMDA receptor binding in epileptic human hippocampus. J Neurosci 1991 0.85
20 Evidence that zinc inhibits N-methyl-D-aspartate receptor-gated ion channel activation by noncompetitive antagonism of glycine binding. Mol Pharmacol 1990 0.83
21 Activation of substantia nigra neurons: role in the propagation of seizures in kindled rats. J Neurosci 1986 0.83
22 Pharmacological evaluation of 1229U91, a novel high-affinity and selective neuropeptide Y-Y1 receptor antagonist. J Pharmacol Exp Ther 1995 0.82
23 The kindling model of epilepsy: a critical review. CRC Crit Rev Clin Neurobiol 1985 0.82
24 Enhanced delayed matching performance in younger and older macaques administered the 5-HT4 receptor agonist, RS 17017. Psychopharmacology (Berl) 1998 0.81
25 Different densities of 5-HT3 receptors are labeled by [3H]quipazine, [3H]GR 65630 and [3H]granisetron. Neuropharmacology 1993 0.81
26 (R) and (S) RS 56532: mixed 5-HT3 and 5-HT4 receptor ligands with opposing enantiomeric selectivity. Neuropharmacology 1994 0.80
27 Role of the substantia nigra in the kindling model of limbic epilepsy. Adv Exp Med Biol 1986 0.79
28 Comparison of 5-HT4 receptors in guinea-pig colon and rat oesophagus: effects of novel agonists and antagonists. Naunyn Schmiedebergs Arch Pharmacol 1996 0.79
29 Conjugation and bioactivation of chlorotrifluoroethylene. Life Sci 1981 0.78
30 Intranigral dynorphin-1-13 suppresses kindled seizures by a naloxone-insensitive mechanism. Brain Res 1987 0.78
31 A radiohistochemical measure of [3H]TCP binding to the activated NMDA-receptor-gated ion channel in rat brain. Brain Res 1990 0.78
32 The role of substantia nigra in the development of kindling: pharmacologic and lesion studies. Brain Res 1987 0.77
33 Evidence implicating alpha-2 adrenergic receptors in the anticonvulsant action of intranigral muscimol. J Pharmacol Exp Ther 1987 0.77
34 Effect of polybrominated biphenyls on hepatic microsomal metabolism of estrogens and uterotropic action of administered estrogen in rats. J Toxicol Environ Health 1982 0.76
35 Subcellular distribution of neuroactive amino acids in brains of genetically epileptic rats. Epilepsia 1984 0.76
36 High-affinity interactions of ligands at recombinant guinea pig 5HT7 receptors. J Comput Aided Mol Des 2001 0.76
37 The effects of aluminum on microtubular integrity using in vitro and in vivo models. Toxicol Lett 1980 0.75
38 Cardiac and hepatic effects of pre- and postnatal exposure to polybrominated biphenyls in rats. J Toxicol Environ Health 1982 0.75
39 Sulfur amino acids and the brain. Introduction. Prog Clin Biol Res 1983 0.75
40 Pharmacological characterization of N-methyl-D-aspartate receptors in spinal cord of rats with a chronic peripheral mononeuropathy. Neuropharmacology 1998 0.75
41 A method for identifying Ca ionophores using a unicellular organism. J Pharmacol Methods 1980 0.75
42 The interaction of taurine and glutamate metabolism in brains of genetically seizure susceptible and seizure resistant rats. Proc West Pharmacol Soc 1985 0.75
43 Displacement of protein-bound thiopental by sodium methiodal may contribute to anesthetic complications during canine myelography. Am J Vet Res 1981 0.75
44 Activity of locus coeruleus neurons in amygdala kindled rats: role in the suppression of afterdischarge. Brain Res 1987 0.75
45 Allosteric modulation of [(3)H]gabapentin binding by ruthenium red. Neuropharmacology 2000 0.75
46 Method of lesioning brainstem determines seizure probability. J Neurosci Methods 1986 0.75
47 Radiohistochemical demonstration of NMDA/glycine-channel activation in rat hippocampus. Eur J Pharmacol 1988 0.75
48 NMDA receptor plasticity in the kindling model. Adv Exp Med Biol 1990 0.75
49 Possible bases for the anticonvulsant action of taurine. Prog Clin Biol Res 1983 0.75
50 The identification of heterogeneity of 5-HT3 receptors with [3H]RS-42358-197. Adv Exp Med Biol 1995 0.75